- $1.04bn
- $2.45bn
- $1.44bn
Brief: UTZ Brands reports Q2 results
Brief: UTZ Brands To Report Q2 2022 Results On August 11, 2022
NYSE ORDER IMBALANCE 56665.0 SHARES ON SELL SIDE
NYSE ORDER IMBALANCE 85630.0 SHARES ON SELL SIDE
Utz Brands jumps after Goldman upgrades to "buy"
NYSE ORDER IMBALANCE 53546.0 SHARES ON BUY SIDE
Utz Brands jumps on raising 2022 sales forecast
Brief: UTZ Brands Files For Offering Of Up To 2.1 Million Shares Of Stock By Selling Stockholders
Brief: Utz Brands To Add New Manufacturing Facility In Kings Mountain, Nc
NYSE ORDER IMBALANCE 56983.0 SHARES ON BUY SIDE
U.S. STOCKS ON THE MOVE-Lixte Biotechnology, Boeing Co, Worksport Ltd
U.S. STOCKS ON THE MOVE-Astra Space, Biodesix Inc, Kohl's Corp
U.S. STOCKS ON THE MOVE-Meta Platforms, Lixte, Kohl's Corp, BioCardia
U.S. STOCKS ON THE MOVE-Aeglea Bio, CrowdStrike Holdings, Hoth Therapeutics
Credit Suisse downgrades UTZ Brands to 'neutral'
NYSE ORDER IMBALANCE 94740.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 102928.0 SHARES ON BUY SIDE
Brief: Utz Brands Reports Fourth Quarter And Full-Year 2021 Financial Results
UTZ Brands Inc reports results for the quarter ended in December - Earnings Summary